ArticlePDF Available

BP measurements and hypertension in infants, children, and adolescents: from the postmercury to mobile devices

Authors:

Abstract and Figures

A mercury sphygmomanometer (MS) has been the gold standard for pediatric blood pressure (BP) measurements, and diagnosing hypertension is critical. However, because of environmental issues, other alternatives are needed. Non-invasive BP measurement devices are largely divided into auscultatory and oscillometric types. The aneroid sphygmomanometer, the currently used auscultatory method, is inferior to mercury sphygmomanometers in terms of limitations such as validation and regular calibration and difficult to apply to infants, in whom Korotkoff sounds are not audible. The oscillometric method uses an automatic device that eliminates errors caused by human observers and has the advantage of being easy to use; however, owing to its measurement accuracy issues, the development of an international validation protocol for children is important. The hybrid method, which combines the auscultatory and electronic methods, solves some of these problems by eliminating the observer bias of terminal digit preference while maintaining measurement accuracy; however, the auscultatory method remains limited. As the age-related characteristics of the pediatric group are heterogeneous, it is necessary to reconsider the appropriate BP measurement method suitable for this indication. In addition, the mobile application-based BP measurement market is growing rapidly with the development of smartphone applications. Although more research is still needed on their accuracy, many experts expect that mobile application-based BP measurement will effectively reduce medical costs due to increased ease of access and early BP management.
Content may be subject to copyright.
CEP Clin Exp Pediatr Vol. 65, No. 2, 7380, 2022
https://doi.org/10.3345/cep.2021.00143
Review article
A mercury sphygmomanometer (MS) has been the gold
standard for pediatric blood pressure (BP) measurements, and
diagnosing hypertension is critical. However, because of environ-
mental issues, other alternatives are needed. Noninvasive BP
measurement devices are largely divided into auscultatory and
oscillometric types. The aneroid sphygmomanometer, the cur
-
rently used auscultatory method, is inferior to MS in terms of
limita tions such as validation and regular calibration and diffi cult
to apply to infants, in whom Korotkoff sounds are not audible.
The oscillometric method uses an automatic device that elimi
-
nates errors caused by human observers and has the advantage
of being easy to use; however, owing to its measurement
accuracy issues, the development of an inter
national validation
protocol for children is important. The hybrid method, which
combines the auscultatory and electronic methods, solves some
of these problems by eliminating the observer bias of terminal
digit preference while maintaining measurement accuracy;
however, the auscultatory method remains limited. As the age-
related characteristics of the pediatric group are heterogeneous,
it is necessary to reconsider the appropriate BP measurement
method suitable for this indication. In addition, the mobile
application-based BP measurement market is growing rapidly
with the development of smartphone applications. Although
more research is still needed on their accuracy, many experts
expect that mobile application-based BP measurement will
effectively reduce medical costs due to increased ease of access
and early BP management.
Key words: Blood pressure, Child, Mercury, Oscillometry,
Auscultatory
Key message
· Hypertension is defined as a blood pressure (BP) >90th
(elevated) or 95th (hypertension) percentile in children by
height, age, and sex and >95th percentile in neonates by age,
birth weight, and sex.
· Although the oscillometric method can be used for screenings,
the auscultatory method remains the gold standard. The
hybrid method employs the auscultatory and electronic
methods and can reduce bias.
· BP measurement mobile device applications have a potential
for development.
Introduction
Blood pressure (BP) measurement is a common and imperative
component of physical examinations in children and adults.
Although the prevalence of hypertension in children is lower
than that in adults, its early detection is crucial for preventing
later complications. Before recognizing the BP as normal or
high, we must ensure its accurate measurement. BP in children
can be affected by several factors such as measurement technique,
emotional state, and activity level. The accommodation effect
and measurement device type are 2 critical factors for BP mea
-
surement accuracy in children. The accommodation effect
refers to the fact that BP usually decreases as measurements are
repeated. Therefore, multiple BP measurements are recommend
-
ed before the diagnosis of elevated BP.1) There are several methods
for measuring BP, including the mercury sphygmo
mano meter
(MS). First introduced more than 110 years ago, the MS has
been the gold standard method for obtaining BP and diagnosing
hypertension in children. However, because of environmental
issues related to mercury toxicity, the MS will no longer be used.
This review article describes several BP measurement methods
and speculates on what may replace MS in children.
Corresponding author: Seong Heon Kim, MD. Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, 101
Daehak-ro, Jongno-Gu, Seoul 03080, Korea
Email: pedksh@gmail.com, https://orcid.org/0000-0001-8003-3010
The corresponding author previously worked in Pusan National University Children's Hospital but is currently working in Seoul National University Children's Hospital.
Received: 4 February, 2021, Revised: 14 August, 2021, Accepted: 19 August, 2021
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-
nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2022 by The Korean Pediatric Society
Blood pressure measurements and hypertension in infants,
children, and adolescents: from the postmercury to mobile
devices
Seon Hee Lim, MD1, Seong Heon Kim, MD2
1Department of Pediatrics, Uijeongbu Eulji Medical Center, Uijeongbu, Korea; 2Department of Pediatrics, Seoul National University Children's Hospital, Seoul National
University College of Medicine, Seoul, Korea
Clinical and Experimental Pediatrics [Epub ahead of print]
Lim SH and Kim SH. The alternatives of pediatric BP measurement in nonmercury era
www.e-cep.org
74
usually higher than auscultatory BP measurements.2) Consider
-
ing these 2 guidelines, elevated BP is diagnosed using an aus
-
cultatory device in pediatric patients.
2. Definition of neonatal hypertension
The measurement of BP in newborns is important but diffi
-
cult. Newborns, especially preterm infants, undergo rapid
physiological changes before and after birth, but possible
rapid changes in blood flow and BP make it difficult to classify
measured BP. Neonatal hypertension is identified when the
systolic BP measured 3 times is higher than the 95th percentile
in the BP classification by gestational age, birth weight, and
sex.6,7) The evaluation of hypotension in newborns is also
important. Hypotension is identified when the systolic BP is
less than the 5th–10th percentiles by gestational and postnatal
age.7) In extremely low birth weight infants, information on a
normal BP is insufficient; therefore, mean arterial BP, which is
lower than the newborn’s gestational age in weeks, is clinically
used as a treatment criterion.7) In neonates, especially in cases
of arterial catheterization through the umbilical artery, intra-
arterial BP through the catheter is the gold standard method for
neonatal BP measurements.6,8) Neonatal movement, feeding,
catheter position, and appropriate catheter size for the vessel
Definition of hypertension in children
1. Definition of pediatric hypertension
After the American Heart Association (AHA) and American
College of Cardiology proposed that a BP higher than 115/
75 mmHg increases one’s risk of cardiovascular disease and
mortality, it lowered the standard adult cutoff value of hyper
-
tension. In 2016, the European Society of Hypertension (ESH)
guidelines suggested that a normal BP was less than the 90th
percentile for persons aged 1–16 years and less than 130/85
mmHg for persons aged over 16 years.2) In 2017, the American
Academy of Pediatrics (AAP) guidelines changed the standard of
an elevated pediatric BP to that above the 90th–95th percentiles
by height, sex, and age for persons aged 1–13 years and above
120/80 mmHg for persons over 13 years of age in line with the
decrease in adult standard3-6) (Table 1). If BP measured by the
oscillometric device is above the 90th percentile, auscultatory
BP should be measured repeatedly, and if the average of BP is
also higher than the 90th percentile, it is considered elevated;
in contrast, if it is less than the 90th percentile, it is considered
normal and monitored with an oscillometric device.5) The
ESH recommended the confirmation of hypertension using an
auscultatory device since oscillometric BP measurements are
BP measurement in children: auscultatory and oscillometric device
Aneroid sphygmomanometer Hybrid auscultatory device Oscillometric electronic device
Next generation:
mobile application-based
BP measurement
The gold standard of HTN diagnosis
When auscultation is difficult
(neonate or small children)
Apply to 24hr ABPM
Pros
Direct estimation of BP
Inexpensive
No need for calibration
Elimination of bias
(terminal digit preference)
Easy to use
Fewer observer errors
Good for screening
Cons
Skilled observer needed
Regular calibration needed Same as aneroid Standard validation protocol needed
Manufacturer variation
Graphical abstract. BP, blood pressure; HTN, hypertension; ABPM, ambulatory BP monitoring.
Table 1. Definition of hypertension
17,41,42)
Neonates
Definition of HTN ≥95th percentile for gestational age, birthweight, and sex on 3 separate occasions
Significant HTN 95th–99th percentile for age and sex
Severe HTN ≥99th percentile for age and sex
Children
1–13 Years ≥13 Years
Normal BP <90th percentile <120/<80 mmHg
Elevated BP ≥90th percentile to <95th percentile or 120/80 mmHg to <95th percentile (whatever is lower) 120/<80 to 129/<80 mmHg
Stage 1 HTN ≥95th percentile to <95th percentile + 12 mmHg, or 130/80 to 139/89 mmHg (whatever is lower) 130/80 to 139/89 mmHg
Stage 2 HTN ≥95th percentile + 12 mmHg or ≥140/90 mmHg (whatever is lower) ≥140/90 mmHg
BP, blood pressure; HTN, hypertension.
www.e-cep.org
https://doi.org/10.3345/cep.2021.00143
75
may change intra-arterial BP; therefore, caution is required
in judgment.9) However, if catheter insertion is not indicated,
methods other than intra-arterial BP monitoring, which is highly
invasive, should be considered. Oscillometric devices are used in
newborns, as their Korotkoff sounds are almost inaudible using
auscultatory devices.
What are the auscultatory methods?
Blood circulation in the body is caused by the continuous
pumping action of the heart, which creates a pulsating flow when
it drains blood from the left ventricle to the aorta. The systolic
BP (SBP) is defined as the maximum pressure exerted against the
inner walls of the blood vessels when the left ventricle contracts,
while the diastolic BP (DBP) is defined as the force exerted during
relaxation and dilation of the heart.10) A noninvasive auscultatory
method that easily measures arterial BP using a stethoscope and
the bladder of the BP cuff was developed about 110 years ago
by Nikolai Korotkoff.11) Despite efforts to establish a superior
BP measurement method, the auscultation method by Korotkoff
remains the gold standard. Initially, Korotkoff described 4 sound
phases, to which a fifth phase was added later. The pressure at the
first audible sound during the slow loosening of the inflated cuff
(Korotkoff phase I) was recorded as the SBP, while the pressure
at the moment all sounds (Korotkoff phase V) disappear was
recorded as the DBP. A sphygmomanometer and stethoscope are
required to measure arterial BP using Korotkoff’s auscultatory
method.
A sphygmomanometer is a device attached to an inflatable
bladder (cuff) through a rubber tube and consists of a pressure
gauge or mercury column. The auscultation method using an
MS is the gold standard for recording BP. An MS usually does
not require calibration since the density of mercury cannot be
changed, although periodic maintenance is necessary, such as
filter cleaning.12) Due to environmental and personal health
concerns, international efforts have been made to discard
healthcare sources of mercury in the thermometer and sphygmo
-
manometer and replace them with less toxic alternatives.13,14)
Therefore, the clinical standard of auscultatory methods using
mercury columns has given way to oscillometric devices in
recent adult guidelines.15) However, the MS is considered the
standard device for BP measurement in epidemiological surveys
in adults.16) Moreover, in children, it should be noted that the BP
table for the diagnosis of hypertension was made based on values
using an MS.2,17) There is a need for a method that can replace
MS for measuring BP and diagnosing hypertension in children
and adolescents.
1. Aneroid sphygmomanometer
The aneroid sphygmomanometer is a device in which a
mercury pressure gauge is replaced by a set of bellows and
mecha nical springs.18) However, unlike with MS, the aneroid
sphygmomano meter may involve intermanufacturer differences
in accuracy. Studies of its accuracy in clinical settings have
reported varied results, with the frequency of defective devices
varying from zero to more than 35%.18-20) Another major concern
of aneroid sphygmomanometers is the issue of maintenance
and recalibration, which is not needed for the MS. This device
should be regularly (no more than every 6 months) calibrated for
accuracy using dynamic calibration methods as recommended
in validation protocols.21) A simple way to check the calibration
is to verify that the needle is not pointed to 0 mmHg when the
manometer valve is open.12)
1) Advantages
Auscultatory BP measurement directly measures SBP and
DBP through Korotkoff sounds. It is inexpensive and portable
and does not require electricity, making it the gold standard for
pediatric BP measurement and hypertension diagnosis.3-5)
2) Disadvantages
A common disadvantage of the auscultatory method is the
requirement for an experienced examiner to perform the
measurement. Also, mismeasurements due to examiner error
are possible (Korotkoff sounds are difficult to hear, especially
in young children), resulting in the underestimation of SBP or
confusion of Korotkoff phases IV and V.10) As mentioned above,
auscultating the Korotkoff sounds using small vessels of neonates
is difficult, and pressing the stethoscope down on the arm causes
bias since it increases the diastolic pressure. Therefore, use of the
auscultatory method for newborns is not recommended.9)
2. Hybrid sphygmomanometer
Hybrid sphygmomanometers are another type of aneroid
sphygmomanometer that combines electronic and auscultatory
devices. The measurement of BP with a stethoscope is the same
as that of an MS.18,22) The Accoson Greenlight 300, a hybrid
sphygmomanometer, is the first nonautomated and mercury-
free device that meets the international protocol for adults
with guaranteed accuracy. It can fulfill the desire expressed by
a consensus of experts representing the AHA.23,24) Thereafter,
it became known that devices such as the A&D UM101
hybrid device (A&D Co., Ltd., Toshima Ku, Tokyo, Japan), Pic
Indolor Professional hybrid device (Pic Indolor Professional,
Artsana Co., Milan, Italy), and Nissei DM3000 (Nissei Japan
Precision Instruments, Gunma, Japan) could replace the MS in
the validation study of the ESH international protocol 2010.25)
Hybrid devices also have advantages of improving auscultatory
BP measurements as they have a self-zeroing feature; thus, they
can obviate the surveillance protocol that is required to ensure
aneroid BP measurement device accuracy.24)
1) Advantages
The auscultatory method remains the gold standard for
diagnosing hypertension in pediatric patients. Hybrid devices
have an electronic pressure gauge but do not use a specific manu
-
facturer’s algorithm. The cuff pressure is accurately displayed
Lim SH and Kim SH. The alternatives of pediatric BP measurement in nonmercury era
www.e-cep.org
76
on a digital light-emitting diode to eliminate terminal digit
preference by the measurer.18)
What are the oscillometric devices?
Oscillometric devices have the advantage of eliminating
human observer errors since they all provide a digital readout of
the BP. Unlike the auscultatory method, oscillometry calculates a
person’s SBP and DBP, and each manufacturer of oscillometric
devices uses its own algorithm for the calculation by examining
the reflected oscillating pulse wave that is generated inside the
deflating bladder.10,12) A typical oscillometric device automati
-
cally inflates the cuff and then gradually deflates it to a pressure
below the diastolic pressure. The oscillations begin above the
systolic pressure and continue below the diastolic pressure so the
SBP and DBP can only be estimated indirectly according to some
empirically derived algorithms. Even a child’s small movements
can affect oscillometric pulses, which are essential to determining
an accurate BP; therefore, it is challenging to measure BP in
children who cry, shiver, or move.
The empirical nature of oscillometry requires validation of
each model’s accuracy.26) Although many devices are marketed
by different manufacturers, less than 15% pass validation studies.
This issue is crucial in children, in whom few devices have been
successfully validated using an established protocol.27) Recent
studies described models that have been validated in children,
and we can read a device’s user manual to see whether validation
was performed and what protocol was used.27) Oscillometric
devices are convenient because their measurements are fully
automated, they do not require training, and they have good
interrater reliability. However, their accuracy in children remains
uncertain. Each method mentioned above has advantages and
disadvantages (Table 2).
1. Ambulatory BP monitoring
Ambulatory BP monitoring (ABPM) is a method of repeatedly
measuring BP several times over a certain period (usually 24
hours). ABPM uses the oscillometric and auscultatory methods,
but the former is mainly used because of the disadvantages of the
latter, specifically measurement difficulties and the absence of a
normal reference value. The BP cuff is wrapped around the arm,
a small monitor is connected, and the BP is repeatedly measured
every 15–30 minutes while the device is connected to the body.
The measured BP is stored, and when the test is completed, the
data are downloaded to the computer and analyzed.28,29) The
interpretation of the results follows AHA guidelines. Through
this method, the mean value and day/nighttime ambulatory BP
information of BP are provided to enable the identification of
hidden variations of hypertension. ABPM can confirm an office
Table 2. The advantages and disadvantages of each method
10,18,28-30,43)
Aneroid auscultation Hybrid auscultation Oscillometry
Method of
BP estimation
Detection of Korotkoff sounds through a
stethoscope for auscultation
Combination of features of electronic and
auscultatory devices (auscultat
ing Koro
-
tkoff sounds and indicating cuff pressure
on digital light-emitting diode readout)
Detection of arterial flow (oscillometry) in
which pulses sensed through the cuff are
filtered, amplified, processed, and applied
to an algorithm to estimate systolic and
diastolic BP
Advantages - Direct estimation of SBP/DBP (more
accurate)
- Inexpensive and portable
- Dose not require electricity
- Same as aneroid
- No need for regular recalibration
- Cuff pressure exactly indicated as a digital
light-emitting diode value, resulting in
elimination of the terminal digit prefer
-
ence
- Portable
- Easy to use; saves time and clinical
resources (less expertise and training
required when used in the absence of a
healthcare provider)
- Fewer observer errors; minimal obser
ver
bias or terminal digit preference
- Good for screening, home use
Disadvantages - Risk of noise interference
- Expertise and retraining required to avoid
observer error; (1) requires manual dex
-
terity to ensure a proper cuff deflation rate,
(2) requires ex
cellent hearing and vision
- Risk of observer bias and terminal digit
preference
- Requires regular calibration (at least every 6
months); device can lose calibration
(become inaccurate) when jostled or
bumped, leading to false readings
- Same as aneroid except for bias of ter
-
minal digit preference
- Very few devices available to date
- Requires access to a continuous power
source (electricity or battery)
- Requires validation by a standard protocol
(some are only for adults); some are
inaccurate; manufacturer variation due to
proprietary algorithm for estimation
- Device cost and longevity
- Must be replaced periodically because of
mechanical failure
- Many are not suitable for patients with
atrial fibrillation, decreased arterial com
-
pliance, motion, or crying
Pediatric area - To date, it is the gold standard for hypertension diagnosis
- In infant/young children, SBP may be underestimated due to poor hearing of Korotkoff
sounds, or DBP may be incorrectly measured by confusion of Korotkoff phases IV and V
- It can be applied when auscultation is
difficult, such as in small children or
newborns
- When applied to 24-hour ABPM, it can
detect masked hypertension and help
diagnose hypertension in patients with a
high auscultatory BP
BP, blood pressure; DBP, diastolic BP; SBP, systolic BP; AMBP, ambulatory blood pressure monitoring.
www.e-cep.org
https://doi.org/10.3345/cep.2021.00143
77
elevated BP since it excludes white-coat hypertension or detects
masked hypertension; moreover, it can better predict future BP
after adulthood and is known to be particularly related to end-
organ changes (ex, left ventricular hypertrophy). Therefore, the
AAP guidelines recommend that children and adolescents with a
high office BP undergo ABPM to confirm hypertension and that
clinicians consider performing annual screenings of high-risk
groups such as those with chronic kidney disease and diabetes.5)
This method is technically difficult in children under 5 years of
age.28)
1) Advantages
As this method does not require measurer expertise, it is
easy to access, removes measurer bias, and eliminates white-
coat hypertension because it can be measured by the patient
alone.18,28,30) Continuous BP measurements can be performed
in a short amount of time. The advantage of electronic monitors
is that they are less likely to cause inaccuracies in mechanical
devices, such as mercury or aneroid devices, since they eliminate
terminal digit preference by the measurer. It is good to use as a
method of hypertension screening tests, such as school checkups.
As mentioned above, it is difficult to hear the Korotkoff sounds
using auscultation in neonates or infants, so the oscillometric
method is applied instead.
2) Disadvantages
This is an indirect BP measurement, as BP is measured by
calculating SBP and DBP from the mean arterial BP measured
using each manufacturer’s algorithm. In addition, the algorithm
varies for among companies, so BP may vary accordingly. In
addition, the measurement value may vary among patients
with different underlying diseases, so it is difficult to trust the
measurement value in cases of arrhythmia, and the accuracy of
the result is theoretically poor for elderly, diabetic, and dialysis
patients with poor arterial compliance.28,29)
Comparisons of mercury and other devices
1. Mercury vs. aneroid sphygmomanometer
Only a few studies have compared the accuracy of mercury
versus aneroid sphygmomanometers in children. A large study
published in 2012 demonstrated that mean mercury and aneroid
systolic and diastolic BP were highly correlated. There was no
significant difference in mean SBP, but a lower mean DBP (by
-1.53±5.06 mmHg) was seen in the aneroid device group.
Although a small discrepancy in DBP measurements exists
between aneroid and mercury devices, this variation is unlikely
to be clinically significant, suggesting that either device could be
used in research or clinical settings.31) Another comparison study
using data of 727 individuals (127 of whom were 8–17 years
old) in the U.S. National Health and Nutrition Examination
Surveys showed that the mean readings were not significantly
different between the 2 methods except for SBP in patients
aged 8–17 years (mean difference, 1.10 mmHg).16) In a recent
systematic review article, only 3 studies compared aneroid and
MS.32) In an additional study on adults in 2015, the BP measured
using mercury, aneroid, and digital devices in 108 subjects were
analyzed by paired t test. The average SBP was 124.57 mmHg for
digital devices, 124.31 mmHg for aneroid, and 125.01 mmHg
for mercury, and there was no significant difference in mercury-
aneroid, mercury-digital, and aneroid-digital measurements,
so it was argued that a digital device or an aneroid device could
replace a mercury device.33)
2. Mercury vs. oscillometric device
A recent meta-analysis (random-effects model) analyzed 34
studies comparing oscillometric devices with MS performed
before July 2015.32) The oscillometric devices showed higher
SBP than MS, with a pooled effect of about 2.53 mmHg (95%
confidence interval [Cl], 0.57–4.5; P<0.05). In the studies that
passed validation, the pooled effect decreased to 1.75 mmHg
(95% Cl, 0.61–2.81; n=12). There was no significant difference
in DBP, which is defined as Korotkoff phase V. However, in some
studies that defined DBP as Korotkoff phase IV by auscultation,
oscillometric devices underestimated DBP. The limitation of
this study is the large interstudy heterogeneity. Studies in clinical
situations other than school-based studies found no differences,
although these studies comprised only a small proportion
of all studies.32) A study comparing a mercury device and an
oscillometric device in 77 obese pediatric patients aged 5–17
years was published in 2017. The mercury device showed
significantly lower SBP and DBP values than the oscillometric
device (Omron HEM 725 CIC, OMRON Healthcare, Kyoto,
Japan) at 104.0±9.6 mmHg/61.1±9.5 mmHg for the mercury
device and 107.8±14.5 mmHg/71.4±15.8 mmHg for the
electronic device.34) Another meta-analysis published in 2019
compared measurement methods among patients older than
15 years of age in 24 papers and found that the oscillometric
device had a lower SBP (mean difference, -1.75 mmHg;
95% CI, -3.05 to -0.45 mmHg; I2=91.0%) and DBP (mean
difference, -1.20 mmHg; 95% CI, -2.16 to -0.24 mmHg;
I2=95.0%),35) showing contradictory results with those of the
previous study. A sub-group analysis revealed differences among
manufacturing companies. The BpTRU monitor (VSM MedTec
Ltd., Vancouver, Canada) showed lower results than mercury
devices (SBP, -4.08 mmHg; DBP, -2.5 mmHg), and there was
no significant difference with the OMRON BP mercury device
(OMRON Healthcare), but the results differed among devices.
However, this study has a limitation in that its heterogeneity was
exceedingly high. It is important to establish a validation protocol
for the algorithm because the studies published to date reported
conflicting conclusions and differences among manufacturers.
In addition, more research is needed to determine whether
oscillometric devices can replace mercury devices in pediatric
patients.
Lim SH and Kim SH. The alternatives of pediatric BP measurement in nonmercury era
www.e-cep.org
78
Next-generation BP measurements in the
mobile era
Recently, as the tools for BP measurement have diversified
and the mobile market has evolved, a method using a mobile
application for BP measurement has emerged. Instead of
wrapping the bladder cuff around the arm and pumping air into
it, a user simply places a finger on the smartphone to measure BP
and checks the results through the mobile application. When the
patient puts a finger on the smartphone camera sensor, the sensor
emits a 940-nm light-emitting diode, the light of which reaches
the photodetector after passing through the finger.30) This
photoplethysmography (PPG) signal detects changes in blood
flow corresponding to the patient’s natural pulsation, and SBP
and DBP can be measured according to the algorithm of each
application. In 2020, traditional BP using an arterial catheter
and BP using a smartphone were simultaneously measured and
analyzed in 50 adults to determine the accuracy of “BP measured
by applying the PPG signal obtained from the smartphone to
the dedicated app (OptiBP)”.36) The difference between the 2
values showed only the difference of SBP -0.7±7.7 mmHg, DBP
-0.4±4.5 mmHg, and mean BP -0.6±5.2 mmHg, confirming
the accuracy of mobile application-based BP. Another study
compared the BP of senior nursing students (aged over 18 years)
using a traditional automated BP cuff versus that using PPG
signals in Apple iOS health applications. The article reported that
DBP was significantly overestimated by the mobile application
at SBP 122.94 mmHg/DBP 76.62 mmHg in the traditional
method and SBP 125.72 mmHg/DBP 81.86 mmHg in the
mobile method.37) No studies have examined smartphone-based
PPG using BP measurements in children. However, in a study
comparing BP with standard ABPM using pulse transit time, a
cuffless BP measurement method, the mean SBP and DBP of 30
patients aged 10–18 years with primary hypertension or a high
normal BP were evaluated. As a result, the cuffless device showed
a significantly higher BP (standard vs. cuffless device: SBP
123.47±14.91 mmHg and 127.48±15.98 mmHg, P<0.001;
DBP 66.88±11.86 mmHg and 68.52±12.36 mmHg, P<
0.001).38) More research in pediatric populations is needed,
and a certified validation protocol for each manufacturer’s
device and algorithm should be developed. The World
Health Organization technical specification for an automated
noninvasive BP measuring device with a cuff showed concern
that BP measurements using smartphone application are in the
early stages of research and development and may lead to wrong
clinical decision due to the absence of validation protocols and
inaccuracy of measurements and expressed the expectation
that it improves hypertension diagnostics by increasing interest
and ease of BP measurement.30) It is currently in the early stage
of research, and we expect that the subject will be expanded
to children and adolescents in the future. If the problem of
low accuracy is improved, it will be possible to improve the
quality of medical care and reduce medical costs for vulnerable
populations.
Which device will replace the MS in children?
A recent study of Korean adults compared the accuracy
and errors of BP measured by 2 types of non-MS devices in an
epidemiologic survey.39) The researchers alternatively used an
MS and 2 electronic devices and calculated the BP measurement
differences, defined as BP measured by MS minus BP obtained
by 2 electronic devices. The concordance correlation coefficients
were not significantly different for SBP (mean differences: -0.52
and -0.62 mmHg, P=0.76; concordance correlation coefficients:
0.97 and 0.94), but the concordance correlation coefficient for
DBP were significantly different among manufacturers (mean
differences: -0.78 and 6.23 mmHg, P<0.01; concordance
correlation coefficients: 0.95 and 0.76).39) In 2018, a similarly
designed study of the Korean National Health and Nutrition
Examination Survey Program was conducted in children over 10
years of age to determine which BP measurement device is most
suitable for replacing MS in future surveys. A direct comparison
among the 3 devices under well-controlled BP measurement
protocols suggested significant differences among manufacturers
in children and adolescents as seen in adults, especially for DBP
(unpublished data). Two recent guidelines for hypertension in
children recommended that oscillometric devices may be used
for BP screening in children, and if they detect hypertension,
the values must be confirmed using the auscultatory method.
They emphasize that at least 3 BP measurements obtained at rest
by manual auscultation are essential when diagnosing a child
or adolescent with hypertension.2,17,40) ABPM may also help
diagnose hypertension in cases of elevated manual auscultatory
BP values.3,5)
In conclusion, although oscillometric devices have become
widely used in children, they have not yet completely replaced
MS or other auscultatory methods, especially for confirming
hypertension in children. The aneroid or hydrid auscultatory
device can be a good alternative to MS, and hybrid devices have
the advantage that they usually do not require regular calibration
of aneroid devices. There is a need for further discussion about
a BP measurement device that can replace mercury, and it can
be said that the mobile application-based BP measurement has
very high development potential because of its convenience and
accessibility, even though it is still in the early stages of research.
Footnotes
Conflicts of interest: No potential conflict of interest relevant to
this article was reported.
Acknowledgments: I acknowledge the Korean Working Group
of Pediatric Hypertension members dedicated to the research
and treatment of hypertension in children.
ORCID:
Seong Heon Kimi
iD
https://orcid.org/0000-0001-8003-3010
www.e-cep.org
https://doi.org/10.3345/cep.2021.00143
79
References
1. Eliasdottir SB, Steinthorsdottir SD, Indridason OS, Palsson R, Edvards
-
son VO. Comparison of aneroid and oscillometric blood pressure mea
-
surements in children. J Clin Hypertens (Greenwich) 2013;15:776-83.
2. Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S,
Hirth A, et al. 2016 European Society of Hypertension guidelines for
the management of high blood pressure in children and adolescents. J
Hypertens 2016;34:1887-920.
3. Ashraf M, Irshad M, Parry NA. Pediatric hypertension: an updated
review. Clin Hypertens 2020;26:22.
4. Benenson I, Waldron FA, Porter S. Pediatric hypertension: a guideline
update. Nurse Pract 2020;45:16-23.
5. Weaver DJ Jr. Pediatric hypertension: review of updated guidelines.
Pediatr Rev 2019;40:354-8.
6. Giri P, Roth P. Neonatal hypertension. Pediatr Rev 2020;41:307-11.
7. Park HK. Optimal blood pressure in preterm infants. Neonatal Med
2014;21:99-105.
8. Dionne JM, Bremner SA, Baygani SK, Batton B, Ergenekon E, Bhatt-
Mehta V, et al. Method of blood pressure measurement in neonates and
infants: a systematic review and analysis. J Pediatr 2020;221:23-31.e5.
9. Moss AJ. Blood pressure in infants children and adolescents. West J Med
1981;134:296-314.
10. James GD, Gerber LM. Measuring arterial blood pressure in humans:
Auscultatory and automatic measurement techniques for human biolo
-
gical field studies. Am J Hum Biol 2018;30(1). https://doi.org/10.1002/
ajhb.23063. [Epub].
11. Lewis WH. The evolution of clinical sphygmomanometry. Bull N Y Acad
Med 1941;17:871-81.
12. Flynn J, Ingelfinger JR, Portman RJ. Pediatric hypertension. Totowa (NJ):
Humana Press, 2013:131-40.
13. Messelbeck J, Sutherland L. Applying environmental product design to
biomedical products research. Environ Health Perspect 2000;108 Suppl
6(Suppl 6):997-1002.
14. Buchanan S, Orris P, Karliner J. Alternatives to the mercury sphygmo
-
manometer. J Public Health Policy 2011;32:107-20.
15. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison
Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/
ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evalua
-
tion, and management of high blood pressure in adults: a report of the
American College of Cardiology/American Heart Association Task Force
on Clinical Practice Guidelines. Hypertension 2018;71:e13-115.
16. Ostchega Y, Prineas RJ, Nwankwo T, Zipf G. Assessing blood pressure
accuracy of an aneroid sphygmomanometer in a national survey environ-
ment. Am J Hypertens 2011;24:322-7.
17. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels
SR, et al. Clinical practice guideline for screening and management of
high blood pressure in children and adolescents. Pediatrics 2017;140:
e20171904.
18. Pickering TG. What will replace the mercury sphygmomanometer?
Blood Press Monit 2003;8:23-5.
19. Bailey RH, Knaus VL, Bauer JH. Aneroid sphygmomanometers. An
assessment of accuracy at a university hospital and clinics. Arch Intern
Med 1991;151:1409-12.
20. Burke MJ, Towers HM, O'Malley K, Fitzgerald DJ, O'Brien ET.
Sphygmomanometers in hospital and family practice: problems and
recommendations. Br Med J (Clin Res Ed) 1982;285:469-71.
21. Waugh JJ, Gupta M, Rushbrook J, Halligan A, Shennan AH. Hidden
errors of aneroid sphygmomanometers. Blood Press Monit 2002;7:309-
12.
22. Pickering T. The case for a hybrid sphygmomanometer. Blood Press
Monit 2001;6:177-9.
23. Jones DW, Frohlich ED, Grim CM, Grim CE, Taubert KA. Mercury
sphygmomanometers should not be abandoned: an advisory statement
from the Council for High Blood Pressure Research, American Heart
Association. Hypertension 2001;37:185-6.
24. Graves JW, Tibor M, Murtagh B, Klein L, Sheps SG. The Accoson
Greenlight 300, the first non-automated mercury-free blood pressure
measurement device to pass the International Protocol for blood pressure
measuring devices in adults. Blood Press Monit 2004;9:13-7.
25. Stergiou GS, Karpettas N, Kollias A, Destounis A, Tzamouranis D. A
perfect replacement for the mercury sphygmomanometer: the case of the
hybrid blood pressure monitor. J Hum Hypertens 2012;26:220-7.
26. Amoore JN. Oscillometric sphygmomanometers: a critical appraisal of
current technology. Blood Press Monit 2012;17:80-8.
27. Stergiou GS, Boubouchairopoulou N, Kollias A. Accuracy of automated
blood pressure measurement in children: evidence, issues, and
perspectives. Hypertension 2017;69:1000-6.
28. Gillman MW, Cook NR. Blood pressure measurement in childhood
epidemiological studies. Circulation 1995;92:1049-57.
29. Ogedegbe G, Pickering T. Principles and techniques of blood pressure
measurement. Cardiol Clin 2010;28:571-86.
30. World Health Organization. WHO technical specifications for automated
noninvasive blood pressure measuring devices with cuff. Geneva
(Switzerland): World Health Organization, 2020.
31. Shah AS, Dolan LM, D'Agostino RB Jr, Standiford D, Davis C, Testa
-
verde L, et al. Comparison of mercury and aneroid blood pressure mea
-
surements in youth. Pediatrics 2012;129:e1205-10.
32. Duncombe SL, Voss C, Harris KC. Oscillometric and auscultatory blood
pressure measurement methods in children: a systematic review and
meta-analysis. J Hypertens 2017;35:213-24.
33. Hamied LIA, Sofiatin Y, Rakhmilla LE, Putripratama AA, Roesli RMA.
Comparison of mercury, aneroid and digital sphygmomanometer in
community setting. J Hypertension 2015;33:e33-4.
34. Fonseca-Reyes S, Romero-Velarde E, Torres-Gudiño E, Illescas-Zarate D,
Forsyth-MacQuarrie AM. Comparison of auscultatory and oscillometric
BP measurements in children with obesity and their effect on the diagnosis
of arterial hypertension. Arch Cardiol Mex 2018;88:16-24.
35. Park SH, Park YS. Can an automatic oscillometric device replace a mer
-
cury sphygmomanometer on blood pressure measurement? A systematic
review and meta-analysis. Blood Press Monit 2019;24:265-76.
36. Schoettker P, Degott J, Hofmann G, Proença M, Bonnier G, Lemkaddem
A, et al. Blood pressure measurements with the OptiBP smartphone app
validated against reference auscultatory measurements. Sci Rep 2020;
10:17827.
37. Bove LA, Carroll R. Comparing traditional blood pressure with a mobile
health application [Internet]. Chicago (IL): Healthcare Information and
Management Systems Society; 2020 [cited 2021 Aug 26]. Available from:
https://www.himss.org/resources/comparing-traditional-blood-pre ssure-
mobile-health-application.
38. Zachwieja J, Neyman-Bartkowiak A, Rabiega A, Wojciechowska M,
Barabasz M, Musielak A, et al. Comparison of cuff-based and cuffless
continuous blood pressure measurements in children and adolescents.
Clin Exp Hypertens 2020;42:512-8.
39. Choi S, Kim YM, Shin J, Lim YH, Choi SY, Choi BY, et al. Comparison
of the accuracy and errors of blood pressure measured by 2 types of non-
mercury sphygmomanometers in an epidemiological survey. Medicine
(Baltimore) 2018;97:e10851.
40. Brady TM, Stefani-Glücksberg A, Simonetti GD. Management of high
blood pressure in children: similarities and differences between US and
European guidelines. Pediatr Nephrol 2019;34:405-12.
41. Dionne JM, Abitbol CL, Flynn JT. Hypertension in infancy: diagnosis,
management and outcome. Pediatr Nephrol 2012;27:17-32.
42. Report of the Second Task Force on Blood Pressure Control in Children-
-1987. Task Force on Blood Pressure Control in Children. National Heart,
Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987;79:1-25.
43. Batton B. Neonatal blood pressure standards: what is "normal"? Clin
Perinatol 2020;47:469-85.
Lim SH and Kim SH. The alternatives of pediatric BP measurement in nonmercury era
www.e-cep.org
80
How to cite this article: Lee SH, Kim SH. Blood pressure
measurements and hypertension in infants, children, and
adolescents: from the postmercury to mobile devices. Clin
Exp Pediatr [Epub ahead of print]. https://doi.org/10.3345/
cep.2021.00143
... Теоретически, широкий диапазон морфологии волн АД, наблюдаемых у подростков, подчеркивает гетерогенность этой популяции и отражает различные размеры тела и стадии их роста. Молодые люди имеют особые анатомические и физиологические характеристики: или очень эластичные артерии и большие различия между плечевым и центральным АД [26], или малые волны и низкую амплитуду тонов Короткова [27]. У подростков некоторые из вышеупомянутых характеристик гораздо больше похожи на характеристики детей, чем взрослых, на которых проводится большинство проверочных исследований. ...
Article
To avoid under- or overdiagnosis of hypertension, the clinician needs to have firm confidence in the measurement tool. Recently, numerous automatic cuff-based sphygmomanometers have become this tool. The solution to this problem appears to be a wider introduction of device validation (accuracy check) activities in research structures. This review presents a number of aspects that are relevant to the ongoing work to develop a global universal standard for such validation.
... The difference between the blood pressure readings obtained by an MS and the two backup electronic devices was calculated by Lim and Kim (2022), and it was discovered that SBP had a significantly different difference (mean differences: -0.52 and -0.62 mmHg, P=0.76). In order to determine which BP measurement technology is best suited to replace MS in future surveys, a comparable design study of the Korean National Health and Nutrition Examination Survey Program was conducted in 2018. ...
Article
Full-text available
Mobile devices, TVs, and even houses are getting the "smart" treatment, and the demand for self-monitoring is growing. The Working Group of the European Society of Hypertension evaluates blood pressure measuring equipment in order to assist consumers in making informed decisions. This is the first independent device validation report. O'Brien and colleagues, 2001.) Smart blood pressure measurement devices are costly and slow, making them unsuitable for children. Because primary hypertension is more common in adolescents, it is more difficult to obtain products. Grewal, Mattoo, and Kapur, 2023. For the Internet of Things, a smart measuring tool for children's hypertension will be developed, allowing them to live a happy life free of their parents' worry and concern. Providing an IoT-based Smart Pediatric Hypertension System in order to reduce the number of deaths caused by delayed medical attention. IoT and Arduino are used to create a device that measures high blood pressure in children. The main idea is to control conventional hypertension measurement and obstacle detection using an Arduino microcontroller, GSM/GPS tool, blood pressure sensor, IFTTT platform, and lithium batteries. By developing an Internet of Things-based intelligent pediatric hypertension solution, this project aims to provide a profitable and full-time job with respectable employment for everyone, as well as promote balanced, equitable, and sustainable economic development. Comparisons between projects have been made to make selecting the right components easier. The critical components for the IoT-based Smart Pediatric Hypertension for Children alerting System will be identified, and the circuit design will be provided. Data on a variety of issues is collected using samples from hypertensive children aged 4 to 13. To provide accurate hypertension readings, compatibility and light components are used. Wi-Fi enabled Arduino Nano bracelet with blood pressure sensor, notification feature, IFTTT platform, GSM/GPS module, Lithium Batteries, and call and message warning.
... However, children's anatomical and physiological characteristics may pose an obstacle to auscultatory measurement. The limitations of the auscultatory method in children include smaller arm circumferences, narrower and more elastic arteries, large differences between peripheral and central blood pressures, low amplitude of Korotkoff sounds, and difficulties identifying the sounds as they are not easily audible 6 . Household electronic blood pressure measurement is recommended for automated measurements since ambulatory blood pressure monitoring is not easy to apply in most cases 2 . ...
Article
Full-text available
Objective: The increasing prevalence of obesity in children and adolescents has turned hypertension into an important public health issue. In the current literature, auscultatory blood pressure measurement is recommended for the diagnosis of hypertension. The number of studies comparing electronic blood pressure measurement and auscultatory blood pressure measurement is limited. This study aimed to compare auscultatory blood pressure measurement with electronic blood pressure measurement in the children population group aged 5-15 years. Patients and methods: A total of 72 patients aged between 5-15 years without chronic disease were included in the study. Anthropometric measurements (height, weight, body mass index, wrist circumference, mid-upper arm circumference) were performed. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were first measured electronically from the wrist using an Omron Rs7 Intelli It HEM-6232T device, and then auscultatory measurements were performed. Each type of measurement was performed 3 times intermittently. Results: The mean wrist circumference was 14.43±0.22 cm and the mean mid-upper arm circumference was 21.43±0.55 cm. Mean SBP, DBP and MAP measured electronically on the wrist were 104.1±1.5, 65.6±1.3 and 78.1±1.3 mmHg, respectively, and mean SBP, DBP and MAP measured via auscultation were 99.3±1, 61.4±0.7 and 73.6±0.7 mmHg, respectively. Electronically-measured wrist MAP had significantly moderate correlations with mid-upper arm and wrist circumference (r:0.547, r:0.559, p<0.01). Conclusions: Since the differences were less than 4 mmHg in both systolic and diastolic pressures between electronic wrist blood pressure (EWBP) measurement and auscultatory measurement, it appears that electronic measurement may be important in first line of blood pressure screening. Since it is easy and practical to use in the early period, it may be an alternative approach to auscultatory measurement among non-critical pediatric patients.
... The Mobil-O-Graph may be used in children older than three, according to the manufacturer, after multiple validating studies [52][53][54]. Our team has previously used the device on both children and adults [10,20,40,55]. ...
Article
Full-text available
Obese children present a higher cardio-metabolic risk. Measuring vascular biomarkers that assess the evolution of arterial stiffness, subclinical atherosclerosis, and hypertension in such patients could be helpful in the long term. We studied 84 children, aged from 6 to 18 years: 50 obese subjects, versus 34 of normal weight. Clinical examination involved: BMI, waist circumference, waist-to-height ratio, and detection of the presence of acanthosis nigricans and irregular menstrual cycles (the latter in adolescent girls). The carotid intima-media thickness (CIMT) was measured with the Aixplorer MACH 30 echography device. The pulse wave velocity (PWV), augmentation index (AIx), and peripheral and central blood pressures (i.e., SBP, DBP, cSBP, cDBP, and cPP) were acquired through a Mobil-O-Graph device. Obese subjects underwent body composition analysis with a Tanita BC-418. Blood tests were: HOMA-IR, lipid panel, uric acid, and 25-OH vitamin D. All vascular biomarkers presented increased values in obese subjects versus controls. The following cut-off values were significant in detecting obesity: for PWV > 4.6 m/s, cSBP > 106 mmHg for the <12-year-olds, PWV > 4.5 m/s and cSBP > 115 mmHg for the 12–15-year-olds, and PWV > 5 m/s, cSBP > 123 mmHg for the >15-year-olds. AIx is higher in obese children, regardless of their insulin resistance status. Waist circumference and waist-to-height ratio correlate to all vascular parameters. HOMA-IR is an independent predictor for all vascular parameters except CIMT. Cut-off values for PWV of >4.8 m/s, SBP > 125 mmHg, and a cSBP > 117 mmHg predicted the presence of acanthosis nigricans. Obese girls with irregular menses displayed significantly higher PWV, SBP, and DPB. Elevated levels of uric acid, LDL-c, non-LDL-c, triglycerides, and transaminases, and low levels of HDL-c and 25-OH vitamin D correlated with higher arterial stiffness and CIMT values. We conclude that CIMT and the markers of arterial stiffness are useful in the early detection of vascular damage in obese children.
... The precision of the aneroid sphygmomanometer depends on the operator's proficiency in auscultation and use of a stethoscope, and visual acuity [35]. More recently, hy-brid sphygmomanometers automate the detection of Korotkoff sounds and the display of the SBP, DSP and pulse rate on digital monitors [37]. To note, Aneroid sphygmomanometers' accuracy has notable variations across manufacturers. ...
Preprint
Full-text available
Blood pressure is a vital sign that offers important insights into overall health, particularly cardiovascular well-being. It plays a critical role in medical settings and homes for disease prevention, diagnosis, treatment, and management. Physicians heavily rely on blood pressure values for making crucial decisions. Most commercial devices utilize cuffs for blood pressure measurement, and automatic devices have gained popularity due to the high prevalence of hypertension. Self-measurement and home monitoring of blood pressure are also recommended. However, concerns arise regarding the accuracy of blood pressure measurement technologies and the alignment of reported values with actual values. People often adjust their medication based on these reported values, making accuracy vital. This study focuses on the concept of ``bias'' to highlight potential discrepancies between reported and actual blood pressure values. Previous research has identified biases originating from three categories: (1) blood pressure measurement devices, (2) subject-specific factors, and (3) measurement sessions. Specifically, this study examines biases associated with cuff-based blood pressure technologies due to their widespread use in medical applications and the growing trend of home monitoring. Identifying and addressing the primary sources of biases is crucial to prevent their propagation and mitigate potential consequences. Additionally, the study explores the future prospects of blood pressure monitoring using machine learning methods.
... The IEM Mobil-O-Graph device was chosen because, in addition to being a validated device [47], its use is facile, reproducible, and has very good acceptability in children. Multiple studies confirm that the oscillometric devices acquire accurate measurements even in children [47][48][49]. ...
Article
Full-text available
Childhood obesity speeds up the development of arterial stiffness and progressively increases the values of arterial pressure. The purpose of this study is to investigate the value of using pulse wave analysis (PWA) to measure arterial stiffness as a sign of vascular wall impairment in obese children. The research was focused on 60 subjects: 33 obese and 27 normal-weight. Ages ranged from 6 to 18 years old. PWA includes parameters such as pulse wave velocity (PWV), augmentation index (AIx), peripheral and central blood pressure (SBP, DBP, cSBP, cDBP), heart rate, and central pulse pressure (cPP). The device used was a Mobil-O-Graph. Blood parameters were taken from the subject’s medical history, not older than 6 months. A high BMI and a large waist circumference are linked to a high PWV. The levels of LDL-c, triglycerides (TG), non-HDL-c, TG/HDL-c ratio, and total cholesterol-HDL-c ratio significantly correlate to PWV, SBP, and cSBP. Alanine aminotransferase is a reliable predictor of PWV, AIx, SBP, DBP, and cDBP, while aspartate aminotransferase is a significant predictor of AIx, mean arterial pressure (MAP), cSBP, and cPP. 25-OH-Vitamin D negatively correlates with PWV, SBP, and MAP and significantly predicts the MAP. Cortisol and TSH levels are not significant to arterial stiffness in obese children without specific comorbidities and neither is fasting glucose in obese children without impaired glucose tolerance. We conclude that PWA contributes valuable data regarding patients’ vascular health and should be considered a reliable tool in the management of obese children.
... The device has been validated in adults against the well-established SphygmoCor applanation tonometry device, combining the measurement of brachial BP, pulse wave analysis and central BP in one measurement [31][32][33]. Although the oscillometric noninvasive methods of acquiring this data are not completely validated in children, there are multiple studies that affirm that these devices' accuracy is comparable to mercury sphygmomanometry [34][35][36]. The main issue seems to be the accuracy of the systolic peripheral BP and the central systolic BP, which, according to Mynard et al., could be overestimated [37]. ...
Article
Full-text available
Early detection of all complications of childhood obesity is imperative in order to minimize effects. Obesity causes vascular disruptions, including early increased arterial stiffness and high blood pressure. This study’s aim is to assess the reliability of pulse wave analysis (PWA) in obese children and how additional risk factors influence the evaluated parameters. We analyzed 55 children aged 6–18 years old by measuring their pulse wave velocity (PWV), augmentation index (AIx), peripheral blood pressure (SBP, DBP), heart rate, central blood pressure (cSBP, cDBP) and central pulse pressure (cPP). We used the oscillometric IEM Mobil-O-Graph and performed a single-point brachial measurement. The subjects were divided into two groups: obese (n = 30) and normal-weight (n = 25) and were clinically and anamnestically assessed. BMI and waist circumference are significantly correlated to higher values for PWV, SBP, DBP, cSBP, and cDBP. Weight significantly predicts PWV, SBP, DBP and cPP. The risk factors that significantly influence the PWA and BP values are: a cardiometabolically risky pregnancy (higher PWV, AIx, SBP), active and passive smoking (higher PWV, SBP, cSBP, cDBP), sleep deprivation (higher PWV, SBP, cSBP) and sedentariness (higher PWV, AIx, peripheral and central BP). We conclude that obese children with specific additional cardiometabolic risk factors present increased arterial stiffness and higher blood pressure values.
Article
Full-text available
Regular blood pressure (BP) monitoring in clinical and ambulatory settings plays a crucial role in the prevention, diagnosis, treatment, and management of cardiovascular diseases. Recently, the widespread adoption of ambulatory BP measurement devices has been predominantly driven by the increased prevalence of hypertension and its associated risks and clinical conditions. Recent guidelines advocate for regular BP monitoring as part of regular clinical visits or even at home. This increased utilization of BP measurement technologies has raised significant concerns regarding the accuracy of reported BP values across settings. In this survey, which focuses mainly on cuff-based BP monitoring technologies, we highlight how BP measurements can demonstrate substantial biases and variances due to factors such as measurement and device errors, demographics, and body habitus. With these inherent biases, the development of a new generation of cuff-based BP devices that use artificial intelligence (AI) has significant potential. We present future avenues where AI-assisted technologies can leverage the extensive clinical literature on BP-related studies together with the large collections of BP records available in electronic health records. These resources can be combined with machine learning approaches, including deep learning and Bayesian inference, to remove BP measurement biases and provide individualized BP-related cardiovascular risk indexes.
Article
Objective: Automated cuff blood pressure (BP) devices are widely used for ambulatory, home, and office BP measurement. However, an automated device, which is accurate in the general adult population may be inaccurate in some special populations. A 2018 Collaborative Statement by the US Association for the Advancement of Medical Instrumentation, the European Society of Hypertension, and the International Organization for Standardization (ISO) considered three special populations requiring separate validation (children, pregnancy, and atrial fibrillation). An ISO Task Group was appointed to identify evidence for additional special populations. Method: Evidence on potential special populations was identified from the STRIDE BP database, which performs systematic PubMed searches for published validation studies of automated cuff BP monitors. Devices that passed in a general population, but failed in potential special populations were identified. Results: Of 338 publications (549 validations, 348 devices) in the STRIDE BP database, 29 publications (38 validations, 25 devices) involved four potential special populations: (i) age 12-18 years: three of seven devices failed but passed in a general population; (ii) age more than 65 years: one of 11 devices failed but passed in a general population; (iii) diabetes type-2: four devices (all passed); (iv) chronic kidney disease: two of seven devices failed but passed in a general population. Conclusion: Some evidence suggest that the automated cuff BP devices may have different accuracy in adolescents and in patients with chronic kidney disease than in the general population. More research is needed to confirm these findings and investigate other potential special populations.
Article
Full-text available
Globally hypertension in adults is among the leading preventable cause of premature death, where a graded association from the childhood hypertension is well recognised. With the concurrent rise in obesity and pediatric hypertension (HTN) during the past decade in developed countries, a parallel trend is emerging in developing countries that has a potential for exponential rise in cardiovascular, cerebrovascular and renal tragedies. A cumulative incidence of pediatric HTN in China and India is 50-70 and 23% respectively, is quite disturbing. New guidelines for the detection, evaluation and management of hypertension in children and adolescents published in 2017, where a jump in prevalence of pediatric HTN is observed, rings a call to address this under-attended burning problem; for which a review in pediatric hypertension and its management is warranted.
Article
Full-text available
Abstract Mobile health diagnostics have been shown to be effective and scalable for chronic disease detection and management. By maximizing the smartphones’ optics and computational power, they could allow assessment of physiological information from the morphology of pulse waves and thus estimate cuffless blood pressure (BP). We trained the parameters of an existing pulse wave analysis algorithm (oBPM), previously validated in anaesthesia on pulse oximeter signals, by collecting optical signals from 51 patients fingertips via a smartphone while simultaneously acquiring BP measurements through an arterial catheter. We then compared smartphone-based measurements obtained on 50 participants in an ambulatory setting via the OptiBP app against simultaneously acquired auscultatory systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean blood pressure (MBP) measurements. Patients were normotensive (70.0% for SBP versus 61.4% for DBP), hypertensive (17.1% vs. 13.6%) or hypotensive (12.9% vs. 25.0%). The difference in BP (mean ± standard deviation) between both methods were within the ISO 81,060–2:2018 standard for SBP (− 0.7 ± 7.7 mmHg), DBP (− 0.4 ± 4.5 mmHg) and MBP (− 0.6 ± 5.2 mmHg). These results demonstrate that BP can be measured with accuracy at the finger using the OptiBP smartphone app. This may become an important tool to detect hypertension in various settings, for example in low-income countries, where the availability of smartphones is high but access to health care is low.
Article
Full-text available
The prevalence of pediatric hypertension is growing. Hypertension during childhood remains a major risk factor for adverse cardiovascular events later in life. NPs should be aware of current guidelines on screening, diagnosis, and treatment of hypertension in children to improve care for this patient population.
Article
Full-text available
A few studies have compared auscultation and oscillometric devices with the mercury sphygmomanometer (MS) reference values for blood pressure (BP) measurement in an epidemiologic survey. Four trained observers recorded BP measurements from 766 subjects from general Korean population in 2014 and 2015. Measurements were repeated 3 times for each device, alternately using an MS and 2 electronic devices (EDs; Greenlight 300 vs Omron HEM-907), together with a randomized device sequence. The BP measurement difference was defined as BP measured by MS minus BP obtained by ED, and the absolute error as the absolute value of the difference. Mean differences in systolic BP (SBP) were –0.52 and –0.62 mmHg and those of diastolic BP (DBP) were –0.78 and 6.23 mmHg (P < .01) in the Greenlight and Omron device group, respectively. The concordance correlation coefficients were 0.97 and 0.94 for SBP and 0.95 and 0.76 for DBP in the Greenlight and Omron group, respectively (P < .05). Kappa values for the Joint National Committee 7 BP classification were 0.84 and 0.74 for Greenlight and Omron group, respectively. The prevalence of normotension, prehypertension and hypertension were 53.5%, 33.9%, and 12.5% with the MS and 59.8%, 29.0%, and 11.2% with the ED in the Omron group (P = .03, McNemar test), whereas they were insignificant in the Greenlight group. The Greenlight 300 may be a good alternative to the MS, and the Omron HEM-907 has good accuracy in SBP measurement. Due to the measurement error in DBP, Omron HEM-907 was inferior to the Greenlight device.
Article
Blood pressure (BP) is routinely measured in newborn infants. Published BP nomograms demonstrate a rise in BP following delivery in healthy infants at all gestational ages (GA) and evidence that BP values are higher with increasing birth weight and GA. However, the complex physiology that occurs in newborn infants and range of BP values observed at all GA make it difficult to identify "normal" BP for a specific infant at a specific time under specific conditions. As such, complete hemodynamic assessment should include the physical examination, perinatal history, other vital signs, and laboratory values in addition to BP values.
Article
Objectives To determine the recommended blood pressure (BP) measurement methods in neonates after systematically analyzing the literature regarding proper BP cuff size and measurement location and method. Study design A literature search was conducted in MEDLINE, PubMed, Embase, Cochrane Library, and CINAHL from 1946 to 2017 on BP in neonates <3 months of age (PROSPERO ID CRD42018092886). Study data were extracted and analyzed with separate analysis of Bland-Altman studies comparing measurement methods. Results Of 3587 nonduplicate publications identified, 34 were appropriate for inclusion in the analysis. Four studies evaluating BP cuff size support a recommendation for a cuff width to arm circumference ratio of approximately 0.5. Studies investigating measurement location identified the upper arm as the most accurate and least variable location for oscillometric BP measurement. Analysis of studies using Bland-Altman methods for comparison of intra-arterial to oscillometric BP measurement show that the 2 methods correlate best for mean arterial pressure, whereas systolic BP by the oscillometric method tends to overestimate intra-arterial systolic BP. Compared with intra-arterial methods, systolic BP, diastolic BP, and mean arterial pressure by oscillometric methods are less accurate and precise, especially in neonates with a mean arterial pressure <30 mm Hg. Conclusions Proper BP measurement is critical in neonates with naturally lower BP and attention to BP cuff size, location, and method of measurement are essential. With decreasing use of intra-arterial catheters for long-term BP monitoring in neonates, further studies are urgently needed to validate and develop oscillometric methodology with enhanced accuracy.
Article
Objective: In recent times, new methods of blood pressure measurements have been introduced, including cuffless blood pressure (BP) measurement device using pulse transit time (PTT) for calculation of BP values. However, it is still unknown how values obtained with a new cuffless device compare with standard ambulatory measurements in children. The main aim of the study was to investigate whether BP values measured by a cuffless PTT device are comparable with measurements by a standard upper arm cuff-based BP device. Methods: Thirty children were prospectively included. Blood pressure measurements using the cuffless device (Somnotouch-NIBP) and cuff-based standard device (Omron 907) were performed simultaneously on the left and right arm. Results: Mean systolic BP of the standard measurements was 123,47 ± 14,91 mmHg and 127,48 ± 15,98 mmHg (p < .001) measured by cuffless method. Mean diastolic BP of the standard ABPM measurements was 66,88 ± 11,86 mmHg and 68,52 ± 12,36 mmHg (p < .001). There were significant positive correlations between standard and cuffless measurements. Conclusion: The results show that the created PWV–BP function produces a significant correlation between BP derived from the PWV and the SBP measured by sphygmomanometry. When applying this device in clinical practice, one may keep in mind that the reported mean values over 24 hours, awake and asleep time are not directly interchangeable with cuff-based standard 24-hour BP values. The measured BP values were higher by the new technique. Although differences in SBP between both methods reached values up to 20 mmHg, we think that the development of a cuffless BP monitoring system will provide novel solutions in various medical situations.
Article
Objective: A mercury sphygmomanometer has been considered a gold standard for measuring blood pressure. However, by the Minamata Convention on Mercury, the traditional mercury sphygmomanometer is being replaced by an automated oscillometric device. This study aimed to provide scientific evidence to determine whether an automated oscillometric device can replace a mercury sphygmomanometer and if it is applicable in routine practice. Methods: MEDLINE, EMBASE, the Cochrane Library, and CINAHL were searched on 4 May 2018. Studies comparing blood pressure measurements between automated oscillometric devices and mercury sphygmomanometers were included. Study characteristics were abstracted using the evidence table, and random-effects meta-analyses were conducted. Results: Data were compiled from 24 studies comprising 47 759 subjects. The results of meta-analysis showed that automated oscillometric devices measured lower than mercury sphygmomanometers for both systolic blood pressure (mean differences -1.75 mmHg, 95% confidence intervals: -3.05 to -0.45, I = 91.0%) and diastolic blood pressure (mean differences -1.20 mmHg, 95% confidence intervals: -2.16 to -0.24, I = 95.0%). In sub-group analyses by manufacturer, BpTRU measured lower than the mercury sphygmomanometer and OMRON showed no difference compared to the mercury sphygmomanometer for both systolic and diastolic blood pressure, but the results differed depending on the devices. Conclusion: As a result of this review, the difference in blood pressure between the mercury sphygmomanometer and the automated oscillometric device was within 5 mmHg, but the heterogeneity between the studies was very high. The automated oscillometric devices showed differences in blood pressure results according to the manufacturer and product type.